Medilink Midlands

OUTbio UK and Mills & Reeve Cocktail Making Masterclass
2024-09-04 18:00 - 20:30 (Europe/London) | Mills & Reeve LLP, Botanic House, 100 Hills Road, Cambridge, CB2 1PH, United Kingdom
Join OUTbio UK and Mills & Reeve Solicitors for an exciting cocktail making masterclass at their Cambridge office, located just a few minutes’ walk from Cambridge Station. Whether you’re a cocktail connoisseur or a complete beginner, this event is perfect for learning new skills and networking with like-minded professionals.
This event promises to be a delightful mix of fun and networking, specifically tailored for the Biotech LGBTQ+ community and allies within the Life Sciences sector, it is open to all those who would like to come and network and meet some new and familiar faces over some delicious cocktails/mocktails!
If you’re travelling from London, trains from King’s Cross run frequently and take less than an hour, making it easy to join us for this unique experience. Don’t miss out on this fantastic opportunity to mix, mingle, and master the art of cocktail making!
To register your place, please click here.

Cambridge Tech Week 2024
2024-09-09 - 2024-09-13
Cambridge Tech Week brings together world-leading experts, innovators and investors to fuel growth across the tech ecosystem, establishing Cambridge as a key place where global tech comes to meet.

Attracting entrepreneurs, founders, corporate leaders, investors, government, academia, media and international peers, Cambridge Tech Week offers an unmissable opportunity to share insights and explore future collaborations.
This dynamic event serves as an epicenter for showcasing the latest knowledge and cutting-edge technology, positioning Cambridge, the East of England and the UK in the world tech spotlight.
Cambridge Tech Week is a great opportunity not to be missed! To register your interest for any of the many exciting events held during Cambridge Tech Week 2024, please click here.
To receive a special Medilink Midlands 15% discounted rate, please email events@medilinkmidlands.com
Further information, including sponsorship opportunities, can be found here.

Medical Fair Asia 2024
2024-09-11 - 2024-09-13 | Marina Bay Sands, 10 Bayfront Avenue, Hotel Towers 1, 2, 3, 018956, Singapore
PROMOTE YOUR PRODUCTS AND SERVICES TO THE SOUTHEAST ASIA REGION
With a well-established history since 1997, Medical Fair Asia continues to grow from strength to strength as South East Asia’s most established international medical and healthcare event. Focused on equipment and supplies for the hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors, MEDICAL FAIR ASIA provides you with the best business opportunities to navigate the marketplace in South East Asia. The last edition of this exhibition attracted 1,050 international exhibitors and over 14,000 trade visitors from 70 countries & regions. The physical event will be complemented by a week-long digital extension, to ensure exhibitors and visitors can continue networking and doing business with a global audience.
To register your place, please click the link below to complete the booking form.
Medical Fair Asia 2024 Booking Form

IN-PERSON EVENT: MedTech Strategic Innovation Gateway - The Future of Healthcare with AI
2024-09-12 09:30 - 13:00 | STEAMHouse Birmingham, Belmont Row, Birmingham, B4 7RQ, United Kingdom
With thanks to our event hosts:
The Medilink Midlands Strategic Innovation Gateways create an environment for innovation, knowledge exchange, business opportunities and networking.
Delivered in partnership with a select consortium of experts from academia, clinicians and industry, the Medilink Midlands Strategic Innovation Gateways (SIG) will help to create intelligence and data which will be used to inform policy making and influence national and regional strategies for the sector.
Medilink Midlands invites you to join the second in the series of SIG events, to expand your knowledge of the medtech space, specifically, the future of healthcare with Artificial Intelligence (AI).
As a region, the Midlands houses one of the greatest health and life sciences clusters and the largest number of medtech companies in the UK, with over 1,200 life sciences businesses supporting over 33,000 high skilled jobs, and an economy worth more than £200bn a year.
Home to rapidly growing cluster of digital health companies and more digital startups than any other UK area outside of London – the Midlands is the powerhouse for the medtech and life sciences industry.
This event offers a gateway to representatives who can offer support and guidance with medtech developments and innovations, connect you with academic, business and clinical communities to help forge collaborative partnerships.
Programme:
9:30am – Registrations and Refreshments
10:00am – Welcome and Introductions, Professor Philip Breedon, Professor of Smart Technologies, Nottingham Trent University and Chair of the MedTech Strategic Innovation Gateway
10:05am – Transforming Healthcare Through AI-Powered Innovation, Dr Junaid Arshad, Professor in Cyber Security, Birmingham City University
10:15am – AI and Intellectual Property in Healthcare, Simon Cooper, Managing Director, Adamson Jones
– Why does it matter?
– Opportunities and threats
– Recent legal developments, case studies and examples
– Recommendations
10:40am – Reimagining operating rooms with AI vision, Maks Kozarzewski, COO, VitVio
11:05am – Refreshments, Break and Networking
11:30am – AI Regulations and Medical Devices: Artificial Hope or Intelligent Solution, Richard Bassett, Principal Regulatory Consultant, DLRC
– Exploring various types of AI and their applications in healthcare
– Essential regulatory considerations for integrating AI into medical devices
– The impact of AI Act and Medical Device Legislation on AI-driven healthcare innovations
11:55 – Integrating AI and Human-Centred Design in Healthcare: A Path to Better Outcomes, James Lomas, Co-Founder/CTO, Blüm Health Ltd
12:20pm – Closing Remarks Professor Philip Breedon, Professor of Smart Technologies, Nottingham Trent University and Chair of the MedTech Strategic Innovation Gateway
12:30pm – Lunch and Networking
Cost and tickets:
Registrations are now closed. If you would like to book a ticket, please email events@medilinkmidlands.com.
£20 plus VAT for members of Medilink
£40 plus VAT for non-members
£10 plus VAT for students
To receive the member or student discount code email events@medilinkmidlands.com.
Please enter the code when you purchase your tickets and the amount will be amended automatically.
Speaker Profiles:

MedTech SIG Chair: Professor Philip Breedon, Professor of Smart Technologies, Nottingham Trent University
Philip holds multiple positions and interests surrounding medical technologies, with his research interests and latest projects centred on new and emerging technologies and materials, including surgical robotics, extended reality technologies and environments, the surgical pathway and investigative research related to the utilisation of ‘smart materials’ for medical applications.

Dr Junaid Arshad, Professor in Cyber Security, Birmingham City University
Junaid is a Professor in Cyber Security at Birmingham City University. He has 15 years of research experience and expertise in investigating and addressing cybersecurity challenges for diverse computing paradigms such as High Performance Computing, Cloud computing, IoT, and blockchain. He is actively engaged in investigating the opportunities and threats of Machine Learning and AI, exploring the use of AI-based systems to address specific challenges as well as security and trustworthiness of ML and AI systems.
Junaid is continuously engaged with businesses to support their needs especially with respect to digital transformation and trustworthy use of technological advancements to solve everyday problems. He has led number of projects in collaboration with industrial partners funded by Innovate UK and other third party funding agencies. He is currently leading BCU team for West Midlands Healthtech Innovation Accelerator (WMHTIA) project where the team is supporting 15+ Healthtech organisations within West Midlands region with their specific product development and technology enhancement needs, many of which are focused on leveraging AI and ML to advance their products.
Junaid is an alumnus of the Innovate UK & DCMS funded CyberASAP programme, commercially prototyping the CyMonD system for effective monitoring & defence of IoT-based systems against cyber-threats. Junaid has successfully achieved research funding from UK and overseas funding agencies, and has worked as a security specialist for a number of EU funded projects with experience of developing bespoke security solutions. Junaid has successfully published high quality research within cybersecurity and has more than 70 publications at high quality venues including journals, book chapters, conferences and workshops. He regularly serves on editorial boards and programme committees of different journals and conferences.

Simon Cooper, Managing Director, Adamson Jones
Simon is managing director of Adamson Jones, a dedicated firm of patent and trade mark attorneys within the professional services group Gateley.
Simon’s patent practice covers a wide range of different technologies, but with a particular focus on medical devices, including mechanical, electrical, and software-based technology for medical applications. Simon has particular experience working for successful, innovative manufacturers and spin-out companies, assisting his clients in navigating competitor IP rights, and creating patent, registered design and registered trade mark portfolios around valuable technology and product ranges.

Maks Kozarzewski, COO, VitVio
Maks is the COO at VitVio, a startup using computer vision and AI to make operating rooms more efficient. Before joining VitVio, Maks led UK’s top-ranked team competing in the SpaceX Hyperloop Pod Competition, gaining him Forbes “25 under 25” title for his contributions to the space. He also developed medical diagnostic devices at a leading technology consultancy and has experience in public policy. He holds a Mechanical Engineering degree from the University of Edinburgh.

Richard Bassett, Principal Regulatory Consultant, DLRC
Richard is a medical device quality and regulatory professional, with a comprehensive background encompassing the utilisation, research, and manufacturing of medical devices and in vitro diagnostics (IVDs). Currently serving as a Principal Regulatory Consultant at DLRC, a renowned regulatory affairs consultancy with a team of over 80 highly qualified regulatory professionals, Richard operates from the UK office, contributing to DLRC’s success in strategically located offices across the UK, Germany, and the US.
Richard brings over 14 years of extensive experience within the medical device industry. He has held roles including quality management, regulatory compliance, and clinical strategy development. His expertise extends to effective supplier engagement and guiding product development. Richard’s professional journey has traversed roles with a legal manufacturer, consultancy positions, and contributions to a Notified Body. Richard holds a master’s degree in molecular biology, complemented by a second master’s degree in medical law, which specifically focused on UK and EU Medical Device Regulations. His dedication to sharing and imparting his knowledge is evident through his five-year tenure as a lecturer on medical device regulatory affairs at Cambridge University, where he has made valuable contributions to the BioEnterprise MSc course. As a Principal Regulatory Consultant at DLRC, Richard continues to bring his wealth of knowledge and hands-on experience to navigate the complex landscape of medical device regulations, contributing to DLRC’s reputation as an award-winning consultancy.

James Lomas, Co-Founder/CTO, Blüm Health Ltd
James has demonstrated a diverse and impactful career spanning several key positions. With over a decade of experience, he has been pivotal in various leadership roles. At Blüm Heath, he currently holds the position of Co-Founder and Chief Technical & Product Officer since October 2019. In this capacity, he has built and advised the product and technical strategy, whilst growing and managing the respective teams.
James has previously worked in leadership roles within large tech companies, most recently at Blue Prism. Complex systems were a part of the Blue Prism software ecosystem, pioneering the category of Robotic Process Automation, a field recognised globally for its innovation, with Blue Prism being voted into the MIT top 50 smartest companies from 2016-2021. James has successfully coordinated and delivered product leadership, solution design and execution of the cloud portfolio of products during this period up until their acquisition by SS&C. He also championed and established the Design System with internal and external interactions within teams and customers for future products.
His expertise spans diverse sectors, including Finance, Venture Capital, Banking, FinTech, and Health Tech. His extensive experience in project leadership, coupled with his technical proficiency, has enabled him to drive innovation and growth within these organisations. In the Finance and Venture Capital sectors, he has collaborated with stakeholders to identify procedural frictions, commercial opportunities, and develop strategies aligning with market trends, innovation landscape, and financial goals. His contributions in Banking and FinTech involve developing technology-driven solutions to enhance financial services and customer experiences, while ensuring regulatory compliance. In Health Tech, as indicated by his work with clients like the NHS, he focuses on integrating technology to improve healthcare delivery and outcomes. His experience working with both public and private companies has given him a deep understanding of various organisational structures and market dynamics.
This event is in collaboration with:

WEBINAR: Navigating the Red Tape - Discussing Regulatory updates for MedTech in the UK
2024-09-12 13:00 - 14:30 | Online
Are you a MedTech manufacturer looking to stay ahead in the UK market?
Join this exclusive webinar, hosted by GRS and Med-Di-Dia, to gain expert insights and practical, actionable guidance on the evolving regulatory landscape. Whether you’re focused on medical devices, digital health or in vitro diagnostics, this session will equip you with the knowledge to ensure compliance and market success.
Why Attend?

Unlock Key Insights: Get a detailed overview of the latest UK medical device regulations and the buzz around CE and UKCA marking.
Stay Ahead with the Latest Amendments: Stay updated on the progress and development of UK MDR 2002 and understand how they impact your business, ensuring you’re always ahead of the curve.
Market Access Simplified: Learn about market access requirements for Great Britain and Northern Ireland, including crucial registration and representation obligations.
Future-Proof Your Business: Explore the future of UK MedTech regulations with a roadmap of upcoming legislative milestones and international recognition routes.
Embrace Digital Health: Discover evidence requirements for NHS acceptance of Digital Health Technologies.

Who Should Attend?

MedTech manufacturers
Regulatory affairs professionals
Compliance officers
Quality assurance managers
Product development teams

Don’t miss this opportunity to stay ahead in the dynamic UK MedTech market. Secure your spot today and ensure your products remain compliant and competitive.
To register your place, please click here.

IN-PERSON EVENT: Growing the East of England Health and MedTech Cluster
2024-09-18 10:15 - 14:30 | Mills & Reeve LLP, Botanic House, 100 Hills Road, Cambridge, CB2 1PH, United Kingdom
Attention Health and MedTech companies: If you’re looking to accelerate your growth, don’t miss this event hosted by Medilink Midlands and Health Tech Enterprise.
With over 20 years of experience supporting MedTech and Life Sciences companies, we invite you to hear directly from industry leaders, regional support organisations, and businesses that have already benefited from our assistance.
This event is also your chance to influence the future of support in the East of England and contribute to shaping the vision of a MedTech Cluster in the region.
“SEHTA is delighted to partner with Medilink Midlands to talk to the audience about how SEHTA can support SMEs in the East of England from the MedTech and Life Sciences sector” – Neil Roberts, Managing Director, SEHTA
Don’t miss this opportunity to connect, learn and have your voice heard!
Programme:
10:15am – Registrations, Refreshments & Networking
11:00am – Host Welcome & Introduction, James Fry, Partner, Head of Life Sciences, Mills & Reeve
11:05am – Strategic Overview & Welcome, Melanie Davidson, Chief Executive Officer, Medilink Midlands & Dr Anne Blackwood, CEO, Health Tech Enterprise
11:10am – The role of Health Innovation East in supporting companies to help generate improved heath and wealth in the East of England, Philip Shelton, Head of Industry Partnerships and Net Zero Lead, Health Innovation East
11:30am – Turning ideas into successful medical devices, Danny Godfrey, Co-Founder & Director, eg technology
11:50pm – Leveraging Support for Success: My Journey of Innovation in the NHS, Dr Shaobin Wu, Co-Founder, C-Prio Ltd
12:05pm – Refreshments & Networking
12:20pm – Health Tech Enterprise Support, Max Bardwell, Head of Business Development, Health Tech Enterprise
12:25pm – Medilink Midlands Support, Raghul Senthilnathan, Innovation Adviser, Medilink Midlands
12:30pm – SEHTA Support for SMEs, Neil Roberts, Managing Director, SEHTA
12:35pm – Anglia Ruskin University Support, Dr Beverley Vaughan, Arise Innovation Hubs Director, Anglia Ruskin University
12:40pm – Group Breakouts: What support you would like to see in the East of England and what a MedTech Cluster would look like
13:15pm – Closing Remarks and Next Steps, Melanie Davidson, Chief Executive Officer, Medilink Midlands
13:25pm – Lunch & Networking
CLICK HERE TO BOOK YOUR PLACE*
Please ensure that you secure your free place, as spaces are limited and available on a first come, first served basis, priority will be given to East of England organisations.
*Spaces are now full, to be added to the waiting list email: events@medilinkmidlands.com
Hosted by:

Speaker Profiles:

James Fry, Partner, Head of Life Sciences, Mills & Reeve
James is a leading life sciences lawyer and heads the firm’s multi-disciplinary life sciences practice. He specialises in advising businesses and organisations in the sector on intellectual property matters and complex commercial contracting. In particular, James has longstanding and deep knowledge of research and technology collaborations, intellectual property licensing and the distribution and promotion of medical and medicinal products. He also regularly advises on regulatory issues relevant to the sector, such as product classification, clinical trials and advertising. His clients include GSK, Illumina, F-star, The Binding Site, NRG Therapeutics, Mission Therapeutics and Neurocrine Biosciences. James has been ranked in the Intellectual Property sections of Chambers and Partners for many years. The Directories describe James as “an excellent lawyer” (Legal 500) and “an outstanding IP practitioner and life sciences specialist” (Chambers).

Melanie Davidson, Chief Executive Officer, Medilink Midlands
Melanie brings a background of industrial research and business development from West Pharmaceutical Service’s Drug Delivery Division. She also broadens our bioscience reach having studied Animal Science at The University of Nottingham. Before joining Medilink, Melanie gained valuable experience in economic development and international investment at the East Midlands Development Agency (emda).

Dr Anne Blackwood, CEO, Health Tech Enterprise
Anne is Chief Executive of Health Tech Enterprise (HTE), a leading NHS innovation and technology consultancy based in Cambridge. Anne has been actively involved in intellectual property management and commercialisation of life science technologies for over 20 years. She is also Chair of the Medtech Accelerator, a joint venture with public sector partners that awards proof of concept funding to develop medical technologies that meet a clinical need in the NHS. She was formerly Chair and co-founder of Medovate, a venture backed innovation development company dedicated to the commercialisation of medical technologies created within the NHS. Anne is passionate about improving the quality and efficiency of healthcare services through technology and innovation.

Philip Shelton PhD, Head of Industry Partnerships and Net Zero Lead, Health Innovation East
Philip joined Health Innovation East in 2020 from Philips and has over 20 years’ experience in life sciences, NHS research and implementation and digital health. He specialises in AI and imaging and innovation focusing on helping the NHS reach their Net Zero targets.
As Head of Industry Partnerships and Net Zero Lead within our commercial team he is responsible for consulting and building a range of strategic partnerships with national and internation companies. These include Bayer, Fujitsu, Abbott and AstraZeneca. He is further supporting the two Imaging Networks in the East of England. Philip also takes a lead role in the national Net Zero and sustainability portfolio and recently was commissioned to conduct two evaluation studies on Apollo Phase Change Solutions panels and the Net Zero benefits of the Abbott Indexor pre-analytics system.

Danny Godfrey, Co-Founder & Director, eg technology
Danny co-founded eg technology ltd in 2002, with fellow director Andrew Ede. Based in Cambridge (UK), eg technology is a product design, engineering and development consultancy, specialising in the MedTech sector, which has now grown to employ over 40 engineering and commercial staff. With a BA and MEng in Engineering from Cambridge University and more than 20 years’ experience in product design and engineering, Danny’s role is to provide corporate leadership, develop new business opportunities and oversee the technical and strategic direction of projects. He has in depth knowledge of the entire project life cycle, from the initial proposal writing, technical & creative input, design implementation, review processes and the early identification of development risks. Motivating staff and nurturing client relationships are important aspects of Danny’s day-to-day work – valuing and developing our team of bright, can-do people and ensuring clients are satisfied with what eg does have been the foundations of success for the company.

Dr Shaobin Wu, Co-Founder, C-Prio Ltd
Dr. Shaobin Wu is a Consultant Histopathologist and the newly appointed Trust Clinical Lead for Genomics at East Suffolk and North Essex Foundation Trust. With a deep passion for healthcare innovation, Dr. Wu has played a key role in advancing digital transformation within the NHS. As a Topol Digital Fellow and NHS Clinical Entrepreneur, she has developed valuable skills in agile project management, person-centred design, and the integration of digital technologies in healthcare.
In addition to her clinical roles, Dr. Wu is the Co-founder of C-Prio Ltd, where she takes the leadership role to leverage AI and automation to address critical challenges in NHS histopathology service, particularly in cancer diagnostics. Her entrepreneurial journey is distinguished by the strategic support and funding she has received from the Arise ABOVE program, which have been instrumental in progressing her visionary ideas towards impactful solutions. Through her leadership and commitment, Dr. Wu continues to push the boundaries of what’s possible in healthcare, making meaningful contributions to both clinical practice and the broader entrepreneurial landscape.

Max Bardwell, Head of Business Development, Health Tech Enterprise
An experienced professional in technology development and innovation, Max Bardwell joined HTE in 2022 as Head of Business Development. His role is varied and includes developing new commercial partnerships, opening up new market opportunities and driving sales growth. Max has 20 years of experience in the development of scientific instrumentation and medical technologies and has worked for number of higher education institutions and spin out companies in research, technology transfer and commercialisation of technology innovations. He has experience in the protection and exploitation of intellectual property, project management and effective collaborative strategic partnership between industry and academia. Max has a BSc in Chemistry from Nottingham Trent University, an MBA from the Open University and a PhD in Atmospheric Chemistry from Nottingham Trent University.

Raghul Senthilnathan, Innovation Adviser, Medilink Midlands
Raghul is a dynamic Innovation Adviser with a master’s degree in Biotech and Pharma Management from UCL, he has a very strong background in life sciences and healthcare innovation. He has successfully founded two innovative start ups and has personal expertise in digital technologies. Raghul is skilled in leading accelerator programmes and supporting early stage companies to navigate challenges and realise their potential in contributing to the economy. He also has expertise in coaching, mentoring and business diagnostics to help innovators avoid pitfalls and succeed.

Neil Roberts, Managing Director, SEHTA
Neil has been the Managing Director since April 2021, having previously been COO since July 2018. In July 2022, Neil was appointed non-executive Chairman to the Board of Exhalation Technology Ltd, which has attracted more than £11m in investor funding. In addition he is a business Mentor at Imperial College, London, as part of the Imperial Venture Mentoring Service.
Based on more than 30 years as a Senior Executive in the medical technology market, he has a track record of success in driving business development and growth, via sales and marketing, domestic and international distributor management, market access, major accounts, new business integration, and change management. This has been gained in the UK and in export both within an SME and market leading corporate environment. His approach is based on pragmatism, enabled by detailed market understanding, with the highest importance placed on the execution of consequent action plans as the key to success. He has managed product though NICE Technology Appraisal (TA), and other market access processes. Served as Industry Representative on the RCOphth Working Party into the safety of laser eye surgery in the UK, and as Chair of the Ophthalmic Special Interest Group at the ABHI. A degree in Medical Biochemistry from London University has been enhanced by business management education at Ashridge and the completion of leadership studies at Harvard.

Dr Beverley Vaughan, Arise Innovation Hubs Director, Anglia Ruskin University
Beverley joined the Arise Innovation Hubs as Director in June 2021, with over 20 years’ experience in the healthcare and life sciences sector. Beverley trained as a clinical scientist in Haematology and working at Cambridge and London University Hospitals. Working in the innovation sector for the last 10 years with roles in Stevenage Bioscience Catalyst (SBC), Cell and Gene Therapy Catapult (CGT) and the University of Oxford. Whilst at SBC Beverley supported the development of translational research facilities and raised funding from multiple pharma and biotech companies for the Open Innovation Challenge in Neurodegeneration. At CGT Beverley managed a wide portfolio of project from novel drug discovery spin outs to NHS led delivery of cell therapy products. Most recently she was responsible for the delivery of a drug discovery consortium-UKSPINE- pivoting traditional pathways to meet the demands of healthy aging with partners, Universities of Oxford, Dundee and Birmingham, Medicines Discovery Catapult, The Francis Crick Institute and Sanger Centre Cambridge. Since joining Arise as Director Beverley has been working on building the life science strategy for their newest hub located on the Harlow Innovation Park, leading on strategy, fund raising and partnering activities to build a cluster of expertise within this synapse of the London-Cambridge corridor. She is also a member of the NC3Rs CRACKIT advisory panel.

NIHR i4i FAST Awards Briefing Webinar
2024-09-18 12:30 - 13:50 | Online
The NIHR Invention for Innovation (i4i) Programme is launching another round of the FAST scheme – Funding At the Speed of Translation. This online briefing webinar will provide an opportunity to find out more about the competition, hear from the i4i Programme Director, and how i4i FAST can support innovators.
Agenda
12:30 – 12:35 Welcome
12:35 – 12:45 A FASTer way to accelerate innovation
12:45 – 12:55 Setting the stage: acquired brain injury
12:55 – 13:05 i4i FAST call: The details
13:05 – 13:15 Past i4i FAST award holder
13:15 – 13:45 Q&A session
13:45 – 13:50 Closing remarks
The theme for FAST Call 4 is development of innovative healthcare technologies for acquired brain injury. FAST will open to applications from 18 September 2024, and the deadline for submissions will be 23 October 2024. The available budget is approximately £1.5m. FAST is aimed at innovators in need of a small amount of funding to answer a specific question or to fund a single piece of activity to advance healthcare technologies and interventions for increased patient benefit. Awards are designed to address an evidence gap and innovations must have demonstrated experimental proof of concept as a minimum. For more information, please see the i4i FAST applicant guidance.
Key features of FAST:

Rapid turnaround, approximately 6 to 8 weeks from submission to decision.
Simple application (3 questions and short word limit).
Between £50k to £100k of funding over 6 to 12 months.
Projects must start by 01 February 2025.

IN-PERSON EVENT: Medilink Midlands Members Forum
2024-09-19 09:00 - 12:00 | Adamson Jones part of Gately, Park View House, 58 The Ropewalk, Nottingham, Nottinghamshire, NG1 5DW, United Kingdom
Quarterly Member Forums are an ideal opportunity for members to connect, generate ideas and hear first-hand updates around Medilink Midlands activity. A chance to have your voice heard and input into how your membership can better support our network within the Med-Tech and Life Science Sector.
The next member forum will include an update and round-up of Medilink Midlands activity from Chris Dyke, Head of Connectivity and Joanne Maltby, Head of Projects.
We’re keen to hear from our members in terms of the Medilink Midlands Events Programme. We want to ensure we’re continuously developing and offering events which are informative and fun! And so there’s an opportunity to give your input via roundtable discussion which will be held by our newly appointed Events Manager, Linsey Horsepool.
Member and host, Adamson Jones are patent and trade mark attorneys, specialising in obtaining intellectual property rights for businesses and organisations in the UK, Europe and throughout the world, and will share their insights into how they can support members. So, if you have any IP questions, this is your chance to ask the experts!
Importantly, Adamson Jones will be hosting a mini session which will cover information around the new IP Advance Funding. Find out more about the fund here.
If the invite to this Medilink Midlands member only event hasn’t reached your inbox, please email events@medilinkmidlands.com to receive the details and booking link. Online registration is essential.

Creating a Compelling Value Proposition for the NHS
2024-09-20 13:00 - 14:00 | Online
Join this free webinar from Health Innovation East Midlands and The Association of British HealthTech Industries (ABHI) to understand the critical role that value proposition plays in the success of an innovation.

What are the key components of a value proposition? How do you clearly articulate your product or service for implementation?
Join this free webinar to understand the critical role that value proposition plays in the success and adoption of an innovation.
Being able to create a compelling and clearly articulated value proposition is one of the most common challenges that can become a barrier to stakeholder engagement and health and care system interest. It should be easy to describe and should aim to define the value of the innovation to a range of stakeholders.
Delivered in partnership with ABHI, this webinar will feature speakers from both organisations sharing what makes a good value proposition and covering the support that they can provide to innovators. Speakers will include:

Alison Mlot, Commercial Manager at Health Innovation East Midlands
Richard Phillips, Executive Director, Policy and Partnerships at ABHI

Attendees will also have the opportunity to hear a real world example of an innovation that has seen success.
This webinar is open to everyone, but will be of specific interest to innovators looking to develop a compelling core value proposition that stimulates interest from potential customers, and to NHS colleagues working in transformation, operations and innovation. There will be an opportunity to ask questions to the speakers at the end.
To register your free place, please click here.
If you have any queries or requests about accessibility, please email healthinnovation-em@nottingham.ac.uk

WEBINAR: HDR UK Midlands Data Grand Round
2024-09-17 12:30 | Online
You are invited to join HDR UK Midlands for the monthly data science meeting, HDR UK Midlands Data Grand Round.
This engaging and insightful monthly webinar series is designed for professionals at all levels. Each session brings together leaders, educators, researchers, and experts from various health data fields to share cutting-edge initiatives and foster collaboration. Data Grand Rounds are held online (via Teams) every month during lunchtime, with each session featuring a focused topic of wide-reaching relevance.
The science presentation will be, “Activity and Evaluation Analysis for Neighbourhood Mental Health Teams in Birmingham and Solihull” presented by John O’Neill, Business Insight Lead (Mental Health), Business Intelligence at NHS Birmingham and Solihull ICB, NHS Midlands and Lancashire CSU. Following the presentation, you’ll have the opportunity to participate in an interactive Q&A and discussion.
To find out more and register your interest, please click here.

Mills & Reeve Life Sciences Legal Forum
2024-09-25 10:00 - 11:00 | Online – Zoom
Mills & Reeve invites you to join their Life Sciences Legal Forum.
The regulatory landscape for the life sciences continues to evolve rapidly as the rate of technological advancement within the sector – the development of new drug modalities and the application of digital technology, for example – continues apace. The new Labour government in the UK has also indicated that it will reform regulation to make pathways easier and quicker to navigate.
What are the current regulatory trends for both medicines and medical devices and how do we see regulation developing over the short and mid-term? What do businesses in the sector need to watch out for?
Mills & Reeve’s Head of Sector James Fry will be joined by Isabel Teare, along with regulatory consultants Alisdair Falconer at DLRC, and Timothy Bubb at iMed, to give their collective expert views on these issues.
Upon confirmation of your place, you will have the opportunity to send questions to the speakers in advance. You will also be able to ask questions on the day and the panel will aim to cover all of these during the webinar.
To find out more information, and reserve your place, please click here.
If you need any adjustments to take part in this webinar, please use the requirements form.

WEBINAR: Navigating the latest updates for R&D Tax Credits
2024-09-26 10:00 - 11:00 | Online
Join TBAT Innovation for this insightful webinar with our expert Ian Davie, Senior Consultant, where he will delve into the dynamic landscape of R&D Tax Credits.
In this free 1-hour webinar, you will discover the latest updates, key strategies , and expert insights to maximise your returns. Whether you’re a seasoned professional or new to the field, this session promises invaluable guidance to navigate the complexities of R&D tax incentives effectively.
During the webinar, Ian will discuss:

Latest legislation changes for R&D Tax Credits
Compliance checks with HMRC
What to consider when making a claim

There will be a Q&A session during the webinar, as well as an opportunity to book a free 1-2-1 discussion post-event.
Please click here to register your place.

IN-PERSON: Medilink Midlands Innovation Day 2024
2024-10-03 09:00 - 17:00 | Coventry Building Society Arena, Judds Lane, Coventry, CV6 6GE, United Kingdom
Our flagship event for the who’s who in the Midlands Life Sciences Sector is coming soon, on Thursday 3 October we shall be collaborating and networking at a new venue – Coventry Building Society Arena.
A new venue means, more exhibitors, more networking and more opportunities.
Medilink Midlands Innovation Day will welcome the Midlands life sciences community to Coventry to share the latest inspiring developments from across the sector. The day sits proudly within our annual programme as the flagship event of the year for those in the Life Sciences sector.
The full day event includes:

A conference of high profile sector specific inspiring speakers

An exhibition

Networking opportunities
More to be revealed over the coming months

Centrally located the event pulls together academics, clinicians and businesses from across the Midlands to come together at this renowned event to share ideas/network and forge partnerships.
Bookings are now closed. To enquire about availability, please email events@medilinkmidlands.com.
To read more about Medilink Midlands’ role within the WMHTIA project, click here.
For more information on the wider project, click here to visit the WMHTIA website.
This event forms part of the West Midlands Health Tech Innovation Accelerator (WMHTIA) event series. Medilink Midlands are one of a consortium of delivery partners for the WMHTIA, a project funded by the Department for Science, Innovation and Technology, Innovate UK and West Midlands Combined Authority (part of City Regions).

NIHR i4i FAST Awards Live Q&A Session
2024-10-09 11:00 - 12:15 | Online
The NIHR Invention for Innovation (i4i) Programme is launching Call 4 of the FAST (Funding At the Speed of Translation) funding scheme. FAST is aimed at innovators in need of a small amount of funding to answer a specific question or to fund a single piece of activity to advance healthcare technologies and interventions for increased patient benefit. Awards are designed to address an evidence gap and innovations must have demonstrated experimental proof of concept as a minimum.
Key features of FAST Call 4

Simple application process, fast response
Development of innovative healthcare technologies for acquired brain injury (ABI), including the prevention, diagnosis and management of ABI as well as recovery from ABI
Funding a single activity to address an evidence gap
Applications between £50k and £100k over 6 to 12 months

The event will provide an opportunity to ask questions on eligibility, remit, the application process, finance queries, contracts or IP. If you have any doubts if your proposal is within remit or would like advice about preparing your application, please come along and seek some clarification.
To book your place, please click here.

IN-PERSON EVENT: MTIF and Catapult Cell and Gene Therapy
2024-10-09 13:00 - 18:00 | Nottingham Trent University, Clifton Campus, Clifton Lane, Nottingham, NG11 8NS
NTU and MTIF invite you to attend our interactive event, a collaboration between Medical Technologies Innovation Facility (MTIF) and Catapult CGT at Nottingham Trent University. Learn how MTIF and CGT Catapult use their capabilities and assets to advance the cell and gene therapy sector. Discover how we can provide you with the expertise and resources to develop your own clinically and commercially viable ATMP.
MTIF and CGT Catapult use their capabilities and assets to advance the cell and gene therapy sector. Discover how we can provide you with the expertise and resources to develop your own clinically and commercially viable ATMP. This event will be delivered by experts from across the Cell and Gene Therapy Industry as they discuss a range of topics including:

Translational non-clinical considerations for the development of an ATMP
Cell and Gene Therapy Process Development
CAR-T Therapy Innovations and the Impact on Patients
Exploration of Cell Therapy
Applications in Musculoskeletal Conditions
ATMP Manufacturing Challenges in Academic Settings

We encourage academics, clinicians and researchers from industry to attend this free event. You will have the opportunity to meet with representatives from MTIF, Catapult CGT, as well as other stakeholders from the Cell and Gene Therapy industry.

If you are interested in attending this exclusive event, please complete the Expression of Interest Form.

IN-PERSON EVENT: Growing your life sciences business in the US and China
2024-10-16 09:30 - 14:00 | Santander, The Bradfield Centre, 184 Cambridge Science Park Rd, Milton, Cambridge, CB4 0GA
The pandemic threw the life sciences industry into the spotlight, with the UK emerging as a life sciences superpower. In fact, UK life science exports were worth £24.2 billion in 2021. From aging populations to aging equipment and infrastructure, global markets are calling out for innovative technologies to solve their challenges. No more so than the two largest life sciences markets – the US and China. Between them, they accounted for almost $500 billion worth of medical imports in 2022. And your business could be the answer. But how can you break into these high growth markets?
Santander are hosting an exclusive face-to-face seminar which aims to give you invaluable insights and strategies to effectively navigate and thrive in the two largest healthcare markets in the world.
Join them to:

Discover the market opportunities for your business.
Get tips for navigating the regulatory landscape in both markets.
Explore new partnership opportunities within each market.

Why the US?
As the largest healthcare market in the world, the U.S. healthcare sector’s profit pools are expected to jump from $583 billion in 2022 to $819 billion by 2027.
Key growth areas include:

Medicare advantage.
Outpatient care settings.
Healthcare services and technology (HST).
Specialty pharmacy.

Why China?
China is the 2nd largest healthcare market in the world and is expected to triple in size by 2030.
Despite advancements in the provision of healthcare, China has a long way to meet the wide range of challenges it faces, including:

An ageing population.
Regional and urban/rural disparities.
Medical equipment upgrades.
The diagnosis/treatment/prevention of illnesses and diseases.

Who is this seminar for?
Companies across the life science sector with innovative products and existing or potential ambitions to grow their business internationally, specifically in the US and/or China.
This includes:

Advanced medical devices and technologies.
Digital health solutions.
Biotech.
Pharmaceuticals.

Please note:
The seminar is free-of-charge to attend but subject to confirmation from the event organisers due to limited capacity.
The seminar will cover:

Global Growth for Life Sciences & Insights from Industry Leaders.
Accelerating Global Growth Strategies with Santander Navigator.
Seizing Opportunities in the US & China.
Navigating Key Barriers to Growth in the US & China.

You will also have the opportunity to take part in an interactive Q&A and networking. To register, please click here.

Birmingham Tech Week 2024
2024-10-21 - 2024-10-25
Birmingham Tech Week is a festival of digital, technology and innovation in the West Midlands.

Attended by over 7,500 people, Birmingham Tech Week is the UK’s largest regional tech conference and a great opportunity to learn more from renowned keynote speakers. Events will be taking place across the entire West Midlands, and online, covering a variety of important and innovative topics.

Events will run from Monday – Friday, with an inspiring grand finale of the Evolution Drone Light Show on Saturday. A full breakdown of the main events can be found here.

This is a fantastic opportunity to expand your knowledge and network with other professionals, not to be missed! To find out more, and book your place, please click here.

IN-PERSON: The West Midlands Health Tech Showcase - Birmingham Tech Week
2024-10-22 08:00 - 15:30 | Millenium Point, Curzon Street, Birmingham, B4 7XG, United Kingdom
An all-day event celebrating the region’s world-class health and medtech advancements.

This unique gathering brings together innovators, healthcare professionals, industry leaders, and support networks to explore the latest breakthroughs and collaborative opportunities. Plus, discuss policy and the strategic vision for Tech in Health and Life Sciences.
The event will also feature an exhibition of innovators demonstrating their groundbreaking technologies and solutions, including Aston Vision Science, Championsys and FourPlus Immersive supported through the West Midlands Health Tech Innovation Accelerator (WMHTIA), as well as the Plug and Play Expo, showcasing the latest batch of 11 innovative health tech startups on the Plug and Play accelerator program.
Agenda

8:00 Registration & Exhibition
9:00 Welcome to HealthTech 2024
9:05 Panel: The West Midlands: HealthTech Ecosystem
10:00 WMHTIA presentation
10:30 Break
11:00 Medilink Midlands facilitated discussions::

Political Landscape:
Strategic Vision:

11:30 The Changing Landscape of Healthcare and Life Sciences

Unlocking Healthcare’s Hidden Demand
Panel Discussion

12:30 Lunch
13:30 Plug & Play health tech accelerator batch 2 EXPO
15:30 Exhibition, Networking & Drinks Reception

The WMHTIA is funded by the Department for Science, Innovation & Technology, delivered in partnership with Innovate UK and the West Midlands Combined Authority.

IN-PERSON EVENT: Tech Growth Forum - Attract investment and gain a competitive edge
2024-10-22 09:00 - 11:30 | Marks & Clerk, Alpha Tower, Birmingham, B1 1TT, United Kingdom
As part of Birmingham Tech Week (21-25 October), join Marks & Clerk to learn how to attract investment and gain a competitive edge in the tech industry.
Understanding the commercial potential of intellectual property (IP) is vital for businesses seeking to turn innovation into profit. Businesses that have a clear IP strategy have a higher likelihood of growth, attract greater attention from investors and have increased revenue. This session will help you understand how to use intellectual property to protect the value of your business and how this can help you secure investment in the future.
Our speakers include an investor and the CEO of a successful tech business, who will share their insights on how to grow and attract investment. You will then be able to ask the speakers questions during the panel discussion.
There will also be the opportunity to book a free, confidential 1-2-1 chat with an IP expert at the IP clinic (to take place after the event).
The experts:

Glenn Fletcher, CEO of Tribosonics, a 2024 Tech Climber whose innovative sensing technologies are driving digital transformation.
Surjit Kooner, Investment Director at Midven, a venture capital firm who have invested more than £100m into early-stage businesses and startups to help grow some of the West Midlands’ most exciting businesses.
Philip Cupitt, Martin Hyden and Amy Dunn, Patent and Trade Mark Attorneys from Marks & Clerk, a specialist intellectual property firm.

To view the agenda and book your place, please click here.

IN-PERSON EVENT: HiMed Bootcamp
2024-10-30 10:00 - 16:00 | Arise Innovation Hub, Maypole Boulevard, Harlow, CM17 9TX
China is the second largest and fastest-growing Medtech and Biotech market globally. In recent years, this has led to a heightened investment interest from Chinese Medtech and Biotech companies in the global healthcare and medical research sector.
The Bootcamp will tangibly equip leaders to life science and broader healthcare companies with the knowledge required to develop a successful business strategy for China. The intensive one-day schedule will incorporate sessions on accelerating the path to entrepreneurship, developing a market entry strategy, successful partnering approaches, regulatory pathways, distribution and marketing, market risks, common pitching techniques, and key success factors for introducing healthcare products, technologies, and services into China.
The course integrates the innovative Biodesign theory (The Process of Innovating Medical Technologies), which is the culmination of 16 years of medical entrepreneurship at Stanford University’s Biodesign Research Center. This theory was introduced to China by Professor Chengli Song of USST and has been implemented as the core curriculum of the Bootcamp by HiMed-Joyin since 2017. To date, 20 bootcamps have been successfully delivered, with over 300 entrepreneurs participating in previous sessions. Notably, more than one-third of the companies have reported achieving their goals and experiencing rapid development and growth in their businesses.
This course also encapsulates years of collective experience in the China market and life science commercialization, garnered from specialists, enterprises, and investors, along with insights from other renowned speakers from the global medical industry. By the conclusion of the bootcamp, founders will be equipped to formulate a comprehensive China market entry plan, which will then be presented to a panel of investors and industry experts as a pivotal deliverable.
Hosted at Arise Harlow Innovation Hub
Arise is an Innovation Hub for businesses specialising in the Health, Performance and Wellbeing sectors, and is part of Anglia Ruskin University (ARU). With Hubs strategically located in Chelmsford and Harlow, members can enjoy tailored business support, including access to grant funding, networking opportunities and serviced office facilities.
Arise is supported by the expertise and resources of ARU, providing skills, talent, innovation and business support. Arise is a partnership between ARU and Essex County Council with support from Chelmsford City Council and Harlow Council. This partnership aims to promote business growth in Essex.
To view the full agenda, and register your place, please click here.

IN-PERSON: 2024 SEHTA International MedTech Expo & Conference
2024-11-01 09:00 - 17:30 | Hilton London Tower Bridge Hotel, Tooley Street, London, SE1 2BY
The SME focused healthcare event for driving collaborations between Business, Care & Clinicians & Academics for the MedTech, Lifesciences, Medical Devices, Diagnostics, Digital Health, NHS Sector

For the last 19 years, Science & Engineering Health Technologies Alliance (SEHTA) has developed an excellent reputation for support of its 1,500+ members.
Especially SMEs, through its business support, commercialisation, mentoring and events programmes.
Their 2023 event was an outstanding success. Aimed at SMEs, Corporates, Academics & NHS Healthcare providers, with 45 global sponsors & exhibitors and over 260 registered delegates taking part.
This year, they’re returning for the 4th year to the Hilton London Tower Bridge Hotel on Friday 1st November 2024.

The SEHTA conference and expo helps delegates

Showcase: A range of highly innovative and adoptable technologies
Navigate: Make sense of the complexities of health and social care delivery, and the challenges of accessing the NHS.
Find: Funding opportunities with Investors & Accelerators from both private and public sources
Identify: Current clinical challenges in the NHS

And perhaps most valuable of all… Make new contacts leading to collaborative partnerships at the event.

IN-PERSON: Sustainable Innovation in Healthcare
2024-11-05 10:00 - 15:00 | Charnwood Campus, Bakewell Road, Loughborough, LE11 5RB
Health innovations and treatments that consider climate change, sustainability, and nature should be integral to functioning of a health system. Placing sustainability at the core of the future of healthcare offers opportunities to deliver better treatments, services, support healthier populations, and save costs. The NHS has committed to reaching net zero by 2040 for the emissions they control directly, and by 2045 for the emissions they influence, through the goods and services they buy from partners and suppliers. With all new NHS procurement in requiring a Carbon Reduction Plan or Net Zero Commitment it is essential the business selling to the NHS are actively working on reducing their carbon footprint.
If you are looking for help and advice in how to improve the sustainability of your business join us to hear how our local business leaders are working to deliver their Net Zero plans, from product innovation, to where to start with carbon foot printing, to improving the sustainability of their supply chains into their business, this event will cover topics essential to ensure your business growth is on track.
By attending this event, you will: –

Learn from other business who are taking steps to deliver their Net Zero
Discover what funding and assistance is available
Engage in a panel debate on ways to improve your business road map to Net Zero
Pitch your new sustainable innovation or business process
Network with likeminded businesses

Confirmed Speakers

Nicole McGlennon, CEO Health Innovation East Midlands & Event Chair
Barzin Gavtash, Director of Commercial Strategy – MDI, Kindeva Drug Delivery
Prof Andre Ng, Professor of Cardiac Electrophysiology; Consultant Cardiologist and Electrophysiologist, University of Leicester, President of the British Cardiovascular Society Graeme Cameron, CEO, Pennine Healthcare
Sam Stephens, Director, TBAT Innovation Ltd
Sean James, Arden Tissue Bank Operations Manager, University Hospitals Coventry & Warwickshire NHS Trust
Tim Robinson, Commercial Director, HIEM

Do You Have a Sustainable Innovation or Process that you want to shout about?
We have a limited number of short presentation spots where you can share your latest sustainable innovation or talk about a process change that you have introduced to help your company on its pathway to Net Zero. Presentations slots are five minutes and there is time for two PowerPoint slides.
To book your free tickets, please click here.
We also have a limited number of exhibition opportunities
Headline Sponsors: TBAT Innovation, Kindeva Drug Delivery, Golds Sponsors: Mills & Reeve, Chester Medical
For further information and to book your slot please contact: Lucy.Alexander@charnwoodcampus.com.

IN-PERSON: Patron Social
2024-11-06 14:00 - 16:30 | Everards Brewery, Cooper Way, Everards Meadows, Leicester, Leicestershire, LE19 2AN, United Kingdom
A high-end networking opportunity intended for our Patron Members to enjoy with Medilink Midlands.
This month’s Patron Social is being held at Everard’s Brewery in Leicester.
This event is invitation only and details will shared with Patron contacts via email. If you have missed your invitation please contact events@medilinkmidlands.com.

WEBINAR: Unlocking Funding Opportunities
2024-11-07 10:00 - 11:00 | Online
Join TBAT Innovation for this insightful webinar with our expert Esther Lawrence, Head of Business Development (Grants) where we’ll look at the funding available for UK businesses, and how to utilise the schemes such as Innovate UK Grant Funding.
Innovation is inherently risky, making UK Government funding and assistance a key part of de-risking a new project.
Schemes such as Innovate UK Grant Funding are designed to support and accelerate the research and development your business undertakes.
This webinar will cover:

Current Grant Funding Opportunities & changes to the landscape post-election
How to apply for Funding
Eligibility
Top Tips

There will be a Q&A session during the webinar, as well as an opportunity to book a free 1-2-1 discussion post-event with Esther.
Register here: https://tbat.co.uk/events/webinar-unlocking-funding-opportunities/

IN-PERSON EVENT: Medilink Midlands Innovation Builder Ideation Workshop
2024-11-07 10:00 - 12:30 | Charnwood Campus, Bakewell Road, Loughborough, LE11 5RB
Medilink Midlands, working in partnership with our Entrepreneur in Residence Christian Kumar, has launched the Medilink Midlands Innovation Builder programme, designed to help founders discover a scalable business model for their new innovation.
A highly practical programme, and not a series of theoretical course of lectures, the programme will comprise online events, coaching, peer networks/learning and one-to-one access to an expert network of leading sector experts and investors.
To find out more we are running two Medilink Midlands Innovation Builder Ideation Workshops, 7th November at Charnwood Campus and 8th November in the West Midlands (booking information for the 8th will be available soon).
Programme:
10:00am – Registration, Refreshments and Networking
10:30am – Welcome, Melanie Davidson, Chief Executive Officer, Medilink Midlands
10:35am – Launch details of the Medilink Midlands Innovation Builder, Christian Kumar, Entrepreneur in Residence, Medilink Midlands
12:00pm – Networking
12:30pm – Finish
Open to all those interested in entering the programme or those interested in becoming an Innovation Builder Delivery Partner.

Charnwood Campus Science, Innovation and Technology Park have kindly provided the conference room for the event to take place and we are pleased that Charnwood Campus Life Sciences Talent and Skills Institute are supporting this event. The Charnwood Campus Life Sciences Talent and Skills Institute is a collaborative endeavour between industry and educational partners to address the short- and long-term skills requirements.
CLICK HERE TO BOOK YOUR FREE PLACE ONLINE*
*Please note registration for this event closes at 5pm on Thursday 31st October.

Meet the Facilitator – Christian Kumar, Chief Executive Office, Medtech Makers Lab
Christian brings his extensive experience in corporate finance, investment banking and wealth management. This has been gained over three decades of dedicated involvement in driving strategic growth for various enterprises to help support the ambitions of Medilink Midlands members as they strive to commercialise their own innovations.
Throughout his career, Christian has honed a profound understanding of strategic growth across diverse sectors, and is proud to have played a pioneering role in developing “demand-based” business modelling.

Christian thrives in the dynamic realms of Corporate Finance and Investment Banking, evident in his impressive portfolio encompassing six companies and over 22 investments across sectors such as Leisure, Med Tech, Construction, and Energy.
Currently, he is actively engaged in supporting universities and governmental bodies in devising strategic inbound investment initiatives. His role involves shaping comprehensive expansion strategies that harmonise with their overarching goals, fostering growth and innovation within these institutions.

IN-PERSON EVENT: Medilink Midlands Innovation Builder Ideation Workshop
2024-11-08 10:00 - 12:30 | Salts Healthcare, Unit 1, Richard St, Aston, B7 4AA
Medilink Midlands, working in partnership with our Entrepreneur in Residence Christian Kumar, has launched the Medilink Midlands Innovation Builder programme, designed to help founders discover a scalable business model for their new innovation.
A highly practical programme, and not a series of theoretical course of lectures, the programme will comprise online events, coaching, peer networks/learning and one-to-one access to an expert network of leading sector experts and investors.
To find out more we are running two Medilink Midlands Innovation Builder Ideation Workshops, 7th November (read more, book online here) at Charnwood Campus and 8th November in the West Midlands.
Programme:
10:00am – Registration, Refreshments and Networking
10:30am – Welcome, Medilink Midlands
10:35am – Launch details of the Medilink Midlands Innovation Builder, Christian Kumar, Entrepreneur in Residence, Medilink Midlands
12:00pm – Networking
12:30pm – Finish
Open to all those interested in entering the programme or those interested in becoming an Innovation Builder Delivery Partner.
CLICK HERE TO BOOK YOUR FREE PLACE ONLINE*
*Please note registration for this event closes at 5pm on Friday 1st November.

Meet the Facilitator – Christian Kumar, Chief Executive Office, Medtech Makers Lab
Christian brings his extensive experience in corporate finance, investment banking and wealth management. This has been gained over three decades of dedicated involvement in driving strategic growth for various enterprises to help support the ambitions of Medilink Midlands members as they strive to commercialise their own innovations.
Throughout his career, Christian has honed a profound understanding of strategic growth across diverse sectors, and is proud to have played a pioneering role in developing “demand-based” business modelling.

Christian thrives in the dynamic realms of Corporate Finance and Investment Banking, evident in his impressive portfolio encompassing six companies and over 22 investments across sectors such as Leisure, Med Tech, Construction, and Energy.
Currently, he is actively engaged in supporting universities and governmental bodies in devising strategic inbound investment initiatives. His role involves shaping comprehensive expansion strategies that harmonise with their overarching goals, fostering growth and innovation within these institutions.

MEDICA 2024
2024-11-11 08:00 - 2024-11-14 17:00 | Messe Dusseldorf, Messe Dusseldorf, Stockumer Kirchstraße 61, Dusseldorf, Germany
Medilink UK, the largest representative body in the UK for life science companies, are the exclusive UK partners by Messe Düsseldorf for MEDICA in Germany. Since 2021, Medilink has hosted the largest, most visible group of UK companies attending MEDICA. As a direct result of this success Medilink UK are continuing to expand their presence with a larger UK pavilion at MEDICA 2024. This new, larger and upgraded British pavilion provides UK companies with access to industry leading support at the world’s largest healthcare and life sciences event.
MEDICA has being running for over 40 years, occupying 17 exhibition halls and over 114,000sqm of exhibition space. It regularly attracts several thousand exhibitors from 70 countries (including a huge participation from UK companies) and is now firmly established on every expert’s calendar, underpinning a lot of companies’ annual marketing plans. Each year leading individuals from business, research, healthcare and government visit the exhibition alongside tens of thousands of national and international experts and decision-makers. In previous years, our UK exhibitors were visited by healthcare professionals from as far as the US and South America, Australia, New Zealand, the Middle East and Far East Asia.
What are the options for exhibiting at MEDICA?
Shell scheme: This is our most popular exhibition stand option and each stand comes complete with carpet, electricity, nameboard, lighting and furniture package. We can offer a range of sizes in multiples of 3m.
Pod: The pod is our smallest exhibiting option and is one size only. It is suitable for one member of staff and those with very small products to show, or service providers. The pod comes complete with carpet, electricity, nameboard, lighting, 1 stool, 1 cabinet with graphic backdrop and a shared meeting area. Due to space limitations, companies are not permitted to bring pop-up banners. Any products must fit on top of the lockable cabinet (we can advise of this before signing up).
Space Only: With this option, you would book the raw floor space with Medilink and work with an exhibition contractor to design your own custom-built stand, for an additional cost with them. We can happily recommend our chosen stand builders for a cost-effective and easy experience. This option tends to be for larger spaces, however we can offer a range of sizes in multiples of 3m, with the minimum being 21sqm.
To book your exhibition stand or to discuss your requirements, please contact our friendly and helpful team, here.

IN-PERSON: Patient and Public Involvement and Engagement in Med Tech
2024-11-12 09:00 - 12:30 | Edgbaston Park Hotel and Conference Centre, 53 Edgbaston Park Road, Birmingham, B15 2RS
Join us to understand the importance of patient and public involvement and engagement throughout the med tech development cycle and how its integration from as early as possible can lead to product success.This free event is hosted at the Edgbaston Park Hotel and Conference Centre in Birmingham on Tuesday 12th November 2024, and is sponsored by the West Midlands Health Technology Innovation Accelerator programme (WMHTIA) in collaboration with Medilink Midlands.Free tea, coffee, and pastries will be provided.
Event Programme
9:00 – 9:30 Registration
9:30 – 9:40 Introduction – Sian Dunning, Medical Devices Testing and Evaluation Centre, UHB lead for WMHTIA
9:40 – 10:30 Best practices for engaging with patients throughout the product development lifecycle – Dr Jonathan Gregory, NIHR HealthTech Research Centre in Devices, digital and Robotics (HRC DDR) Digital theme lead
10:30 – 10:50 Refreshments/ Networking
10:50 – 11:15 Equality, Diversity and Inclusion in research and development – Freen Mehdi, Research Inclusion Manager NIHR Birmingham BRC, NIHR HealthTech Research Centre in Devices, digital and Robotics (HRC DDR)
11:15 – 12:05 Case study – shared experience of early patient and public involvement in development of a medical device – Louise Ben -Nathan, Managing Director, LBN Innovations Ltd.
12:05 – 12:20 NIHR HealthTech Research Centre in Devices, Digital and Robotics – Olivia Brookes, Programme Manager, NIHR HealthTech Research Centre in Devices, digital and Robotics (HRC DDR).
12:20 Closing remarks
12.30 Networking
Location:
Composer’s suite, Edgbaston Park Hotel & Conference Centre

IN-PERSON EVENT: Annual Life Sciences conference: Clinical Trials and AI - Legal Challenges and Pitfalls
2024-11-14 09:00 - 14:00 | Pennington Manches Cooper LLP, 125 Wood Street, London, EC2V 7AW
Penningtons Manches Cooper are delighted to invite you to our upcoming conference, “Clinical Trials and AI Legal Challenges and Pitfalls”.
This event is designed to bring together anyone working in the biotech, pharma, techbio, med tech, or tech sectors who are interested in hearing about the legal issues around the use of artificial intelligence (AI) in life sciences and in particular around use involving clinical trials data. Anyone from these sectors are welcomed, whether or not you are early stage or at clinical stage, and whether or not you are already using AI.
The conference sessions include:
Introduction: Unlocking Potential – Using AI in Clinical Research
Hosted by Professor Martin Wilkins, Professor of Clinical Pharmacology, Imperial College, London
Harnessing AI for Clinical Trials: Navigating the Options and Ensuring Regulatory and Data Protection Compliance
Lisa Page (Penningtons Manches Cooper) & Nora Pook (Penningtons Manches Cooper)
This session will delve into the transformative impact of AI on clinical trials, with a particular focus on the use of AI on pre-existing clinical data. The discussion will address key legal considerations, including data protection, consent requirements, and intellectual property (IP) rights:
• Overview of AI systems’ use in clinical trials and regulatory backdrop/requirements for the AI systems UK/EU/FDA
• Initial use case for Pre-screening of patients and any regulatory hurdles
• Data protection considerations and approach with examples also of client advice
• Use cases for clinical trial management/post trial use of data (historical and current)regulatory considerations.
• Data protection aspects for the above use cases especially for use of pt data that is not a part of the trial (Anonymised vs Pseudonymised data).
The Global Landscape of AI and Data Regulation
This session will provide an overview of the regulatory landscape impacting AI, data, and associated rights within life sciences. Our expert panel will cover the UK’s regulatory environment, while external panelists will address key regulatory requirements in other jurisdictions such as in the US and Europe. Discussions will focus on how these regulations influence the development and deployment of AI in biotech and medtech, highlighting compliance strategies and future trends.
Panel Discussion: Real-World Applications of AI in Clinical Trials Data
This panel will share real-world experiences and the discussion will explore practical challenges, successes, and lessons learned, offering attendees valuable insights into the application of AI in the field.
Join us for a morning of insightful discussion, expert opinion and valuable networking opportunities with professionals in the life sciences sector. As part of conference a light breakfast will be served, and lunch to follow the sessions.
To register your place, please click here.
If you have any queries, please email Kelly Ray.

IN PERSON Event: Innovations Against AMR 2024
2024-11-20 10:00 - 16:30 | Enterprise Wharf, Innovation Birmingham, Holt Street, Birmingham, B7 4BB, United Kingdom
We are pleased to announce the 3rd Annual Innovations Against AMR event, taking place place on Wednesday 20th November at Enterprise Wharf in Birmingham.
The event is running during World Antimicrobial Resistance Awareness Week (WAAW), a global campaign to raise awareness of antimicrobial resistance and encourage best practices to prevent the spread of drug-resistant infections. The Theme for WAAW 2024 is “Educate. Advocate. Act now”.
This year, our Innovations Against AMR Event is focused on novel developments within the field of combating AMR throughout the UK, with a special focus on small and medium enterprises. We are interested in hearing from companies in various stages of spinning out and developing their ideas and providing a platform for discussion, collaborations and advocacy against AMR.
This event has grown year on year, bringing together innovators, researchers and other stakeholders working in this sector and has proven a great opportunity for networking and building collaborations. Medilink Midlands are pleased to be partnering with WMHTIA, Bruntwood, Cytecom and the newly established UKRI AMR Network – ARREST AMR to deliver this event:

WMHTIA provides companies access to services and expertise that are essential in critically developing technologies.

Medilink Midlands provides support services to healthcare businesses in the Midlands region, including networking opportunities, business development advice, and access to funding.

Bruntwood SciTech is a property and innovation company that provides flexible workspace and support services to science and technology businesses.

Cytecom is a pioneering SME that has developed a rapid method for diagnosing bacterial infections and advocates for raising awareness about antimicrobial resistance.

The ARREST-AMR (Accurate, Rapid, Robust, and Economical One Health Diagnostics for antimicrobial resistance) network will work alongside seven other networks to bring together diverse expertise from academia, industry, government, regulatory agencies, and charities. They will foster collaborations, drive innovation, and develop effective strategies for implementing fit-for-purpose One Health AMR Diagnostics.

5 Reasons to Attend the 3rd Annual Innovations Against AMR Event
1. Be at the forefront of AMR innovation: Connect with leading innovators, researchers, and industry experts driving advancements in combating antimicrobial resistance. Discover the latest breakthroughs and explore potential collaborations.
2. Support SMEs and foster growth: Learn about innovative solutions developed by small and medium enterprises (SMEs) and contribute to their success. Network with like-minded individuals to create new partnerships and drive innovation.
3. Gain valuable insights and knowledge: Attend engaging presentations and discussions on the latest trends and challenges in the field of AMR. Expand your understanding of the issue and stay ahead of the curve.
4. Network with key stakeholders: Connect with representatives from organisations like Medilink Midlands, WMHTIA, Bruntwood, Cytecom, and the ARREST-AMR network. Build relationships and explore potential partnerships.
5. Contribute to a global cause: Join the fight against antimicrobial resistance by attending this event. Be part of a community dedicated to raising awareness, promoting best practices, and driving positive change.

Agenda
10:00am Registration
10:30am Opening Remarks
10:50am Session 1: Understanding and Tackling the Multidimensional Challenges of AMR
11:05am Arrest AMR Network Introduction
11:35am Role of AMR Diagnostics in Primary Care
11:50am Comfort break
12pm Showcase of Innovators
12:30pm Lunch break
1:15pm Session 2: From Concept to Commercial
2:15pm Showcase of Innovators
2:45pm National Biofilm Innovation Centre
3:15pm Closing Remarks followed by networking
4:30pm Depart

Speaker Information

Dr Enrico Marsili
Dr Enrico Marsili received his PhD in Chemical Engineering from the University of Rome, Italy. After postdoctoral research at University of Minnesota, he took a Lecturer position at Dublin City University. In 2012, he joined the newly formed Singapore Centre for Environmental Life Sciences Engineering, Singapore, as Principal Scientist. In 2019, he moved to Nazarbayev University as Associate Professor in the Department of Chemical and Materials Engineering. Since 2022, he is Associate Professor in Life Sciences and Healthcare at University of Nottingham, Ningbo, China. His research focuses on the characterisation of mixed biofilms using electrochemical methods and the development of novel bioprocess for efficient biosynthesis of commodity chemicals in biofilms. He collaborates with several institutions in China, such as South China University of Technology (SCUT), Shenzhen Institute of Advanced Technology (SIAT) and Shanghai Institute of Materia Medica (SIMM). He has received competitive funding from Collaborative Research Programme and Marine Research Program (National Research Foundation, Singapore), Public Utility Board, Singapore, and municipal level funding (Ningbo, China).

Dr Philip Turner
Dr Philip Turner is a senior researcher in the Infections, Respiratory and Acute care Research Group and the Head of Operations of the HealthTech Research Centre in Community Healthcare (Oxford Health NHS Foundation Trust) based at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. His research interests include the diagnosis and management of common infections and approaches to antimicrobial stewardship in community healthcare settings. Recent activities include co-leadership of the RAPTOR-C19 evaluations of point-of-care tests for SARS-CoV-2 and other respiratory viruses in community care, trial management support for the trans-European VALUE-Dx PRUDENCE RCT of the clinical and cost-effectiveness of diagnostic interventions for RTI, and co-investigation on the NIHR and NHSE-funded TOUCAN evaluation of novel diagnostics for acute uncomplicated UTI.

Dr Abigail Moore
Dr Abi Moore is a practicing GP in London and a clinical researcher in the Infections, Respiratory and Acute Care Research Group based at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. Abi has a clinical and research interest in the care of older people in care homes. Her PhD is on understanding acute functional decline and its relationship to urinary tract infections in this patient group. Abi is co-lead of the DISCO UTI study which is developing new ways to accurately diagnose UTI in care home residents, including approaches incorporating novel diagnostic tests.

To read more about Medilink Midlands’ role within the WMHTIA project, click here.
For more information on the wider project, click here to visit the WMHTIA website.
This event forms part of the West Midlands Health Tech Innovation Accelerator (WMHTIA) event series. Medilink Midlands are one of a consortium of delivery partners for the WMHTIA, a project funded by the Department for Science, Innovation and Technology, Innovate UK and West Midlands Combined Authority (part of City Regions).
